Gene therapy matures in the clinic

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Abstracts Collaborative Meeting of the European Society of Gene and Cell Therapy and the British Society for Gene Therapy. Hum. Gene Ther. 22, A1–A138 (2011).

  2. 2

    Bainbridge, J.W. et al. N. Engl. J. Med. 358, 2231–2239 (2008).

  3. 3

    Maguire, A.M. et al. N. Engl. J. Med. 358, 2240–2248 (2008).

  4. 4

    Maguire, A.M. et al. Lancet 374, 1597–1605 (2009).

  5. 5

    Nathwani, A.C. et al. N. Engl. J. Med. 365, 2357–2365 (2011).

  6. 6

    Raj, D., Davidoff, A.M. & Nathwani, A.C. Expert Rev. Hematol. 4, 539–549 (2011).

  7. 7

    Booth, C., Gaspar, H.B. & Thrasher, A.J. Curr. Opin. Pediatr. 23, 659–666 (2011).

  8. 8

    Cartier, N. et al. Science 326, 818–823 (2009).

  9. 9

    Cirak, S. et al. Lancet 378, 595–605 (2011).

  10. 10

    Aartsma-Rus, A. et al. Eur. J. Hum. Genet. 18, 889–894 (2010).

  11. 11

    Jessup, M. et al. Circulation 124, 304–313 (2011).

  12. 12

    Sheehy, S.H. et al. Mol. Ther. 19, 2269–2276 (2011).

  13. 13

    Schaller, T. et al. PLoS Pathog. 7, e1002439 (2011).

  14. 14

    Li, H. et al. Nature 475, 217–221 (2011).

  15. 15

    Perez, E.E. et al. Nat. Biotechnol. 26, 808–816 (2008).

  16. 16

    Stroncek, D.F. et al. J. Transl. Med. 10, 48 (2012).

  17. 17

    Gollamudi, R. et al. Invest. New Drugs 28, 641–649 (2010).

  18. 18

    Comins, C. et al. Clin. Cancer Res. 16, 5564–5572 (2010).

  19. 19

    Breitbach, C.J. et al. Hum. Gene Ther. 22, A12 (2011).

  20. 20

    Kaufman, H.L. & Bines, S.D. Future Oncol. 6, 941–949 (2010).

  21. 21

    Heo, J. et al. Mol. Ther. 19, 1170–1179 (2011).

  22. 22

    Breitbach, C.J. et al. Nature 477, 99–102 (2011).

  23. 23

    Gaspar, H.B. et al. Sci. Transl. Med. 3, 97ra79 (2011).

  24. 24

    Hacein-Bey-Abina, S. et al. N. Engl. J. Med. 363, 355–364 (2010).

  25. 25

    Gaspar, H.B. et al. Sci. Transl. Med. 3, 97ra80 (2011).

  26. 26

    Aiuti, A. et al. N. Engl. J. Med. 360, 447–458 (2009).

  27. 27

    Grez, M. et al. Mol. Ther. 19, 28–35 (2011).

  28. 28

    Boztug, K. et al. N. Engl. J. Med. 363, 1918–1927 (2010).

  29. 29

    Galy, A. & Thrasher, A.J. Curr. Opin. Allergy Clin. Immunol. 11, 545–550 (2011).

  30. 30

    Cavazzana-Calvo, M. et al. Nature 467, 318–322 (2010).

  31. 31

    Porter, D.L., Levine, B.L., Kalos, M., Bagg, A. & June, C.H. N. Engl. J. Med. 365, 725–733 (2011).

  32. 32

    Kochenderfer, J.N. et al. Blood 119, 2709–2720 (2012).

  33. 33

    Di Stasi, A. et al. N. Engl. J. Med. 365, 1673–1683 (2011).

  34. 34

    Harrington, K.J. et al. Clin. Cancer Res. 16, 4005–4015 (2010).

  35. 35

    Senzer, N.N. et al. J. Clin. Oncol. 27, 5763–5771 (2009).

Download references

Author information

Ethics declarations

Competing interests

L.W.S. owns equity in PsiOxus Therapeutics, a biotech company developing an oncolytic group B adenovirus.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seymour, L., Thrasher, A. Gene therapy matures in the clinic. Nat Biotechnol 30, 588–593 (2012) doi:10.1038/nbt.2290

Download citation

Further reading